NAPIGEN, INC.
Biotechnology ResearchDelaware, United States11-50 Employees
NAPIGEN, INC. is a biotechnology company based in Wilmington, Delaware, focused on genome engineering across plants, microbes, and animals by targeting organelles that contain their own DNA, specifically mitochondria and chloroplasts. The firm aims to enable the modification of these organelles to influence cellular energy production and the synthesis of biochemical molecules involved in key biological pathways, with applications spanning industrial biotechnology, agriculture, and healthcare. Operating within the biotechnology research sector, NAPIGEN positions itself at the intersection of genome editing and organelle biology to explore new capabilities for modifying cellular function. Founded and operating from the Delaware region, the company concentrates on developing its organelle-focused genome technology for diverse use cases, including human cells and agricultural systems, while pursuing collaborations and funding sources that support its research trajectory. A notable recent development involves progress in applying its technology to mitochondrial and chloroplast genomes, signaling ongoing work to expand the scope of its platform beyond basic research into potential applied contexts.
1-888-653-2347 
support@leadiq.com 
